Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00604799 · ClinicalTrials.gov registry record · Phase 2
VALOR: The Talent Thoracic Stent Graft System Clinical Study
A Phase 2 study, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- Phase 2
- Development phase
- 379
- Enrollment target
NCT00604799: Completed Phase 2 study, sponsored by Medtronic Cardiovascular.
NCT00604799 is a Phase 2 study that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 379 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (185% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00604799, a Phase 2 study, has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 379 participants
- Enrollment target
Study Summary
A Descending Thoracic Aneurysm is a bulge in the aorta. The aorta is a large blood vessel that carries blood away from your heart to organs in the rest of your body. Your aneurysm is caused by a weakening in the artery wall. If left untreated, this bulge may continue to grow larger and may ultimately rupture (break open) or extend in size to seriously affect other major arteries in the area. In this Research Study a device will be placed inside your aorta to block the weakened part of the artery wall from the circulatory system. Information will be collected on the performance for the device for 5 years.
Interventions
- DEVICE Talent Thoracic Stent Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2003-07 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
What the finished NCT00604799 record still lists
NCT00604799 is an interventional study that assigns participants to a tested intervention. The registered 379 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (185% higher).
The record links to 0 conditions, and to 1 intervention - of which Talent Thoracic Stent Graft is the first listed.
NCT00604799 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00604799 about?
NCT00604799 is a clinical study titled "VALOR: The Talent Thoracic Stent Graft System Clinical Study". A Descending Thoracic Aneurysm is a bulge in the aorta. The aorta is a large blood vessel that carries blood away from your heart to organs in the rest of your body. Your aneurysm is caused by a weakening in the artery wall. If left untreated, this bulge may continue to grow larger and may ultimatel...
What is the current status of trial NCT00604799?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 379 participants. The study started on 2003-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00604799?
The interventions under investigation include: Talent Thoracic Stent Graft (DEVICE).
Who is sponsoring clinical trial NCT00604799?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00604799's enrollment target sits among peer trials
379 115th of 2000 higher than 1,886 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia